{"id":"https://openalex.org/W2951685357","doi":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","title":"PS951 MORE OR LESS? IMPACT OF DOSE NUMBER ON OUTCOMES OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN","display_name":"PS951 MORE OR LESS? IMPACT OF DOSE NUMBER ON OUTCOMES OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2951685357","doi":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","mag":"2951685357"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000562076.07949.93","doi":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113322170","display_name":"D I Marks","orcid":"https://orcid.org/0000-0002-8641-193X","observed_orcids":["https://orcid.org/0000-0002-8641-193X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.I. Marks","raw_affiliation_strings":["University Hospitals Bristol, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Bristol, Bristol, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.J. DeAngelo","raw_affiliation_strings":["Dana\u2010Farber Cancer Institute Boston MA","Dana-Farber Cancer Institute, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, United States","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112821051","display_name":"E. Jabbour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Jabbour","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center Houston TX","University of Texas MD Anderson Cancer Center, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center Houston TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082944296","display_name":"Anjali S. Advani","orcid":"https://orcid.org/0000-0003-0015-5902","observed_orcids":["https://orcid.org/0000-0003-0015-5902"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Advani","raw_affiliation_strings":["Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102743501","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0003-3386-6540","observed_orcids":["https://orcid.org/0000-0003-3386-6540"]},"institutions":[{"id":"https://openalex.org/I4210096636","display_name":"University of California, Irvine Medical Center","ror":"https://ror.org/00cm8nm15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096636","https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. O\u2019Brien","raw_affiliation_strings":["University of California, Irvine Medical Center, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine Medical Center, Orange, CA","institution_ids":["https://openalex.org/I4210096636"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087124372","display_name":"Tianwang Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Wang","raw_affiliation_strings":["Pfizer Inc, Groton, CT, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Groton, CT, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081736171","display_name":"Alexander Neuhof","orcid":"https://orcid.org/0000-0002-7926-2593","observed_orcids":["https://orcid.org/0000-0002-7926-2593"]},"institutions":[{"id":"https://openalex.org/I4210100293","display_name":"Pfizer (Germany)","ror":"https://ror.org/00m8w3m39","country_code":"DE","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210100293"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Neuhof","raw_affiliation_strings":["Pfizer Pharma GmbH, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Pharma GmbH, Berlin, Germany","institution_ids":["https://openalex.org/I4210100293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009581524","display_name":"Erik R. Vandendries","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Vandendries","raw_affiliation_strings":["Pfizer Inc, Cambridge, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Cambridge, MA, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Kantarjian","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center Houston TX","University of Texas MD Anderson Cancer Center, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center Houston TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[{"id":"https://openalex.org/I4210096636","display_name":"University of California, Irvine Medical Center","ror":"https://ror.org/00cm8nm15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096636","https://openalex.org/I4210137750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Stock","raw_affiliation_strings":["University of California Irvine Medical Center Orange CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Irvine Medical Center Orange CA","institution_ids":["https://openalex.org/I4210096636"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006288618","display_name":"Matthias Stelljes","orcid":"https://orcid.org/0000-0002-9331-5145","observed_orcids":["https://orcid.org/0000-0002-9331-5145"]},"institutions":[{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Stelljes","raw_affiliation_strings":["Universit\u00e4tsklinikum M\u00fcnster M\u00fcnster Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum M\u00fcnster M\u00fcnster Germany","institution_ids":["https://openalex.org/I4210103666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071844603","display_name":"Ryan Daniel Cassaday","orcid":"https://orcid.org/0000-0002-3424-2425","observed_orcids":["https://orcid.org/0000-0002-3424-2425"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Cassaday","raw_affiliation_strings":["University of Washington School of Medicine and Fred Hutchinson Cancer Research Center Seattle WA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington School of Medicine and Fred Hutchinson Cancer Research Center Seattle WA United States","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"S1","first_page":"428","last_page":"429"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inotuzumab-ozogamicin","display_name":"inotuzumab ozogamicin","score":0.9729999899864197},{"id":"https://openalex.org/keywords/relapsed-refractory-acute-lymphoblastic-leukemia","display_name":"relapsed/refractory acute lymphoblastic leukemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/dose-number","display_name":"dose number","score":0.6669999957084656},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5419999957084656},{"id":"https://openalex.org/keywords/minimal-residual-disease-negativity","display_name":"minimal residual disease negativity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.6579999923706055},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hepatic-veno-occlusive-disease","display_name":"veno-occlusive disease","score":0.9779999852180481},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.765999972820282},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7369999885559082},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.7409999966621399},{"id":"https://openalex.org/keywords/treatment-de-escalation","display_name":"treatment de-escalation","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8470485210418701},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6364490985870361},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.5899749994277954},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.581160306930542},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.5429297685623169},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5416122078895569},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4959429204463959},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.43402713537216187},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.34736910462379456},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.hs9.0000562076.07949.93","doi":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000562076.07949.93","doi":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000562076.07949.93","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413783187","https://openalex.org/W3067119682","https://openalex.org/W2971026936","https://openalex.org/W2890085656","https://openalex.org/W2931981435","https://openalex.org/W2949722985","https://openalex.org/W2760857535","https://openalex.org/W2559889175","https://openalex.org/W2589130327","https://openalex.org/W2789799267"],"abstract_inverted_index":{"Background:":[0],"In":[1],"INO\u2010VATE":[2],"(NCT01564784),":[3],"patients":[4,32,86,103,119,127,172,188,250,257,275],"with":[5,13,30,72,79,82,92,181,231,244,271],"relapsed/refractory":[6],"acute":[7],"lymphoblastic":[8],"leukemia":[9],"who":[10,87,104,135,156,189,219],"were":[11,215],"treated":[12],"inotuzumab":[14],"ozogamicin":[15],"(InO)":[16],"vs":[17,123,154,184,200,225,242],"standard":[18],"chemotherapy":[19],"had":[20,136,139,157,220,234],"significantly":[21],"greater":[22],"remission":[23,90,144,209],"rates":[24],"and":[25,75,150,168,191,205,238,254],"longer":[26,141],"overall":[27],"survival":[28,152,236],"(OS),":[29],"more":[31],"proceeding":[33,276,286],"to":[34,110,176,193,277,287,294],"stem\u2010cell":[35],"transplant":[36],"(SCT).":[37],"Aims:":[38],"Here":[39],"we":[40],"report":[41],"outcomes":[42,153,237],"by":[43,115],"number":[44,63],"of":[45,64,117,125,143,163,171,208,249,256,297],"InO":[46,65],"cycles":[47,296],"(Cyc)":[48],"received.":[49],"Methods:":[50],"Methods":[51],"are":[52,59,268],"detailed":[53],"in":[54,85,269],"Kantarjian,":[55],"NEJM":[56],"2016.":[57],"Outcomes":[58],"reported":[60],"based":[61],"on":[62],"Cyc":[66,71,122,130,138,159,183,222,227,233,246,253,260],"received":[67],"(\u22643":[68],"or":[69,77],">3":[70,121,137,182],"no":[73],"SCT":[74,80,278,288],"\u22642":[76,226,232,252,281],">2":[78,221,245,259],"[consistent":[81],"current":[83,272],"recommendations])":[84],"achieved":[88,114],"complete":[89],"(CR)/CR":[91],"incomplete":[93],"hematologic":[94],"recovery.":[95],"Data":[96],"cutoff:":[97],"Jan":[98],"4,":[99],"2017.":[100],"Results:":[101],"Among":[102,187],"responded":[105,190],"but":[106],"did":[107],"not":[108,285],"proceed":[109],"SCT,":[111,194],"MRD\u2010negativity":[112,198],"was":[113,178],"88%":[116],"32":[118],"receiving":[120,128,251,258,292],"61%":[124],"18":[126],"\u22643":[129,158,185],"(P":[131],"=":[132,148,203,213],"0.037).":[133],"Patients":[134,230],"a":[140],"duration":[142,207],"(HR":[145,210],"0.35,":[146],"P":[147,202,212],"0.0005)":[149],"improved":[151,235],"those":[155,218,243,284],"(Table).":[160,247,264],"The":[161],"rate":[162],"serious":[164],"adverse":[165],"events":[166],"(AE)":[167],"the":[169,195,206],"percentage":[170,196],"discontinuing":[173],"treatment":[174],"due":[175],"AEs":[177],"numerically":[179],"lower":[180],"Cyc.":[186],"proceeded":[192],"achieving":[197],"(81%":[199],"69%,":[201],"0.123)":[204],"1.37,":[211],"0.848)":[214],"similar":[216],"for":[217],"(36":[223],"patients)":[224],"(35":[228],"patients).":[229],"non\u2010relapse":[239],"mortality":[240],"(NRM)":[241],"17.1%":[248],"33.3%":[255],"developed":[261],"veno\u2010occlusive":[262],"disease":[263],"Summary/Conclusion:":[265],"These":[266],"results":[267],"agreement":[270],"recommendations":[273],"that":[274],"should":[279],"receive":[280],"Cyc,":[282],"whereas":[283],"may":[289],"benefit":[290],"from":[291],"up":[293],"6":[295],"therapy.":[298],"image":[299]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2019-06-27T00:00:00"}